Furthermore, in hepatocellular carcinoma cells or aggressive B-cell lymphomas, high eIF4E/4E-BP1 confers resistance to metformin-induced apoptosis or mTOR inhibitors, respectively [24, 40]. Here, EIF4EBP1 is linked to hepatocellular carcinoma.